ACELYRIN Inc (SLRN)
ACELYRIN Stockholders Approve Merger with Alumis to Create Clinical Biopharma Company Dedicated to Innovating, Developing and Commercializing Transformative Therapies for Immune-mediated Diseases
ACELYRIN Stockholders Approve Merger with Alumis to Create Clinical Biopharma Company Dedicated to Innovating, Developing and Commercializing Transformative Therapies for Immune-mediated Diseases
Cidara Therapeutics to Participate in Two Upcoming Investor Conferences
Andor Wraps With Season 2 — Here’s Why Disney+ Isn’t Renewing It
Rosen Law Firm Urges West Pharmaceutical Services, Inc. (NYSE: WST) Stockholders to Contact the Firm for Information About Their Rights
Fallout Season 3 Officially Confirmed Before Season 2 Premiere
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm Encourages West Pharmaceutical Services, Inc. (WST) Investors To Inquire About Securities Fraud Class Action
SC 13G/A (Amended Statement of Ownership) SEC Filing
Athira Pharma to Present Data from First-in-Human Phase 1 Clinical Trial of ATH-1105 at the 4th Annual ALS Drug Development Summit
Indivior Notification
Presentation Slides by Medeze Group PCL in relation to the Partial Offer